Aline Millani Carneiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aline Millani Carneiro has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Sergio Tufik
Disciplina de Medicina e Biologia do Sono, Departamento de Psicobiologia, Universidade Federal de São Paulo , São Paulo, Brazil
3 shared publicationsGlaury Coelho
Disciplina de Medicina e Biologia do Sono, Departamento de Psicobiologia, Universidade Federal de São Paulo , São Paulo, Brazil
2 shared publications- Lia Rita Azeredo Bittencourt
Universidade Federal de São Paulo, Brazil
2 shared publications Luciana Badke
Departamento de Pneumologia, Universidade Federal de São Paulo , São Paulo, Brazil
2 shared publicationsAna Dâmaso
Centro de Estudos em Psicobiologia e Exercício (CEPE) São Paulo Brazil
1 shared publication- Cristiane Decat Bergerot
Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Psicologia: Teoria e Pesquisa
- Vol. 38
Avaliação de Prejuízo Cognitivo em Sobreviventes de Câncer de Mama: Estudo Transversal
Resumo Estudo prospectivo e transversal, para determinar a prevalência de prejuízo cognitivo decorrente da quimioterapia e explorar fatores preditores e mediadores em sobreviventes de câncer de mama. Utilizou-se o Termômetro de Distress, Escala de Ansiedade e Depressão, Functional Assessment of Chronic Illness Therapy-General e Cognitive Function. As sobreviventes (N = 62) reportaram uma alta prevalência de distress (46,8%) e de ansiedade (24,2%), com baixos escores nas subescalas déficit cognitivo e habilidades cognitivas percebidos. O funcionamento cognitivo esteve associado à idade (β = 1,42; p = 0,002), atuação profissional (β = -23,12; p = 0,004), depressão (β = -5,43; p = 0,001) e qualidade de vida (β = 1,24; p = 0,001). Prejuízo cognitivo deve ser considerado no serviço de Psico-Oncologia.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Psicologia: Teoria e Pesquisa
- Vol. 38
Open AccessAvaliação de Prejuízo Cognitivo em Sobreviventes de Câncer de Mama: Estudo Transversal
Resumo Estudo prospectivo e transversal, para determinar a prevalência de prejuízo cognitivo decorrente da quimioterapia e explorar fatores preditores e mediadores em sobreviventes de câncer de mama. Utilizou-se o Termômetro de Distress, Escala de Ansiedade e Depressão, Functional Assessment of Chronic Illness Therapy-General e Cognitive Function. As sobreviventes (N = 62) reportaram uma alta prevalência de distress (46,8%) e de ansiedade (24,2%), com baixos escores nas subescalas déficit cognitivo e habilidades cognitivas percebidos. O funcionamento cognitivo esteve associado à idade (β = 1,42; p = 0,002), atuação profissional (β = -23,12; p = 0,004), depressão (β = -5,43; p = 0,001) e qualidade de vida (β = 1,24; p = 0,001). Prejuízo cognitivo deve ser considerado no serviço de Psico-Oncologia.
- 1 February 2018
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 16 (1) , 6-12
Metabolic Profile in Patients with Mild Obstructive Sleep Apnea
Background: Mild obstructive sleep apnea (OSA) is a highly prevalent disorder in adults. However, it is not clear whether mild OSA has significant metabolic complications. This study examined the prevalence of metabolic syndrome (MS) in patients with mild OSA compared to control group. Methods: Adults (18–65 years of age) of both genders with a body mass index (BMI) ≤35 kg/m2 were included. The mild OSA group comprised of patients with an apnea–hypopnea index (AHI) score of ≥5 but ≤15 events/hr of sleep, independent of other symptoms. The control group (CG) comprised individuals with an AHI of Results: Thirty-two percent of mild OSA patients had MS, 43.5% of mild OSA patients had hypertension, 14% showed dyslipidemia, and 56% had prediabetes. The OSA group showed increased TG (CG: 90.0 ± 51.9 vs. OSA: 140.3 ± 78.2 mg/dL, P = 0.004), and TG/HDL-c (CG: 1.9 ± 1.4 vs. OSA: 3.1 ± 2.0, P = 0.05), independent of adjustments. Independent of obesity (BMI 2), there was a negative correlation between total cholesterol and TG with mean oxygen saturation, independent of obesity (BMI 2). Conclusions: Our findings showed dysregulation in lipid profiles after adjustments for confounders in the mild OSA group, and there was a correlation between these parameters and sleep hypoxemia. The TG/HDL-c ratio in particular was high, suggesting that it might be investigated as a marker of a detrimental metabolic profile in these patients.
- 1 February 2018
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 16 (1) , 6-12
Metabolic Profile in Patients with Mild Obstructive Sleep Apnea
Background: Mild obstructive sleep apnea (OSA) is a highly prevalent disorder in adults. However, it is not clear whether mild OSA has significant metabolic complications. This study examined the prevalence of metabolic syndrome (MS) in patients with mild OSA compared to control group. Methods: Adults (18–65 years of age) of both genders with a body mass index (BMI) ≤35 kg/m2 were included. The mild OSA group comprised of patients with an apnea–hypopnea index (AHI) score of ≥5 but ≤15 events/hr of sleep, independent of other symptoms. The control group (CG) comprised individuals with an AHI of Results: Thirty-two percent of mild OSA patients had MS, 43.5% of mild OSA patients had hypertension, 14% showed dyslipidemia, and 56% had prediabetes. The OSA group showed increased TG (CG: 90.0 ± 51.9 vs. OSA: 140.3 ± 78.2 mg/dL, P = 0.004), and TG/HDL-c (CG: 1.9 ± 1.4 vs. OSA: 3.1 ± 2.0, P = 0.05), independent of adjustments. Independent of obesity (BMI 2), there was a negative correlation between total cholesterol and TG with mean oxygen saturation, independent of obesity (BMI 2). Conclusions: Our findings showed dysregulation in lipid profiles after adjustments for confounders in the mild OSA group, and there was a correlation between these parameters and sleep hypoxemia. The TG/HDL-c ratio in particular was high, suggesting that it might be investigated as a marker of a detrimental metabolic profile in these patients.
- 12 November 2015
- Published by Springer Nature in Sleep and Breathing
- Vol. 20 (2) , 681-687
Impaired sustained attention and lapses are present in patients with mild obstructive sleep apnea
Background Severe obstructive sleep apnea (OSA) directly affects the quality of life, mood, and sustained attention of individuals, but it has not yet been established in the literature, if these changes also affect patients with mild OSA. The purpose of this study was to investigate such negative effects on the parameters described above. Methods A controlled study was held at the Universidade Federal de Sao Paulo, Department of Psychobiology. Thirty-nine mild OSA patients and 25 controls were included. Volunteers could be of both genders with body mass index (BMI) ≤35 kg/m2 and age between 18 and 65 years. Both groups were subjected to full-night polysomnography (PSG), the subjective assessment of mood (Beck Inventory of Anxiety and Depression), Functional Outcomes of Sleep Questionnaire (FOSQ), and the psychomotor vigilance task (PVT) five times during the day. We considered mild OSA patients those with apnea–hypopnea index (AHI) score between 5 and 15. The control group included subjects with AHI scores p = 0.004). Conclusions Patients with mild OSA showed increased sustained attention lapses compared with normal subjects.
- 12 November 2015
- Published by Springer Nature in Sleep and Breathing
- Vol. 20 (2) , 681-687
Impaired sustained attention and lapses are present in patients with mild obstructive sleep apnea
Background Severe obstructive sleep apnea (OSA) directly affects the quality of life, mood, and sustained attention of individuals, but it has not yet been established in the literature, if these changes also affect patients with mild OSA. The purpose of this study was to investigate such negative effects on the parameters described above. Methods A controlled study was held at the Universidade Federal de Sao Paulo, Department of Psychobiology. Thirty-nine mild OSA patients and 25 controls were included. Volunteers could be of both genders with body mass index (BMI) ≤35 kg/m2 and age between 18 and 65 years. Both groups were subjected to full-night polysomnography (PSG), the subjective assessment of mood (Beck Inventory of Anxiety and Depression), Functional Outcomes of Sleep Questionnaire (FOSQ), and the psychomotor vigilance task (PVT) five times during the day. We considered mild OSA patients those with apnea–hypopnea index (AHI) score between 5 and 15. The control group included subjects with AHI scores p = 0.004). Conclusions Patients with mild OSA showed increased sustained attention lapses compared with normal subjects.
- 4 April 2012
- Published by Wiley in Cell Biochemistry and Function
- Vol. 30 (6) , 524-529
Short sleep duration and obesity: mechanisms and future perspectives
A reduction of sleep time has become common over the last century, and growing evidence from both epidemiological and laboratory‐based studies suggests sleep curtailment is a new risk factor for the development of obesity. On this basis, the present review examines the role of sleep curtailment in the metabolic and endocrine alterations, including decreased glucose tolerance and insulin sensitivity, increased evening concentrations of cortisol, increased levels of ghrelin, decreased levels of leptin and increased hunger and appetite. It will be discussed how sleep restriction may lead to increase in food intake and result in greater fatigue, which may favour decreased energy expenditure. Altogether, evidences point to a possible role of decreased sleep duration in the current epidemic of obesity and therefore present literature highlights the importance of getting enough good sleep for metabolic health. Many aspects still need to be clarified and intervention studies also need to be conducted. Copyright © 2012 John Wiley & Sons, Ltd.
- 4 April 2012
- Published by Wiley in Cell Biochemistry and Function
- Vol. 30 (6) , 524-529
Short sleep duration and obesity: mechanisms and future perspectives
A reduction of sleep time has become common over the last century, and growing evidence from both epidemiological and laboratory‐based studies suggests sleep curtailment is a new risk factor for the development of obesity. On this basis, the present review examines the role of sleep curtailment in the metabolic and endocrine alterations, including decreased glucose tolerance and insulin sensitivity, increased evening concentrations of cortisol, increased levels of ghrelin, decreased levels of leptin and increased hunger and appetite. It will be discussed how sleep restriction may lead to increase in food intake and result in greater fatigue, which may favour decreased energy expenditure. Altogether, evidences point to a possible role of decreased sleep duration in the current epidemic of obesity and therefore present literature highlights the importance of getting enough good sleep for metabolic health. Many aspects still need to be clarified and intervention studies also need to be conducted. Copyright © 2012 John Wiley & Sons, Ltd.